Abstract: Thyrotropin-releasing hormone (TRH) aroused our interest when we were engaged in related experiments, so we decided to study its effects on organs, tissues, and aging-related metabolic and hormonal markers when administered in acute or chronic (oral) doses at various time points in its cyclic circadian pattern. We also wanted to determine what effects, if any, it had on aging processes in two essential systems, namely gonadal-reproductive and kidney-urinary. Our results show positive changes as a result of short-term acute and long-term chronic oral administration of TRH to old mice that included rapid correction to more juvenile levels of most typical aging-related hormonal and metabolic measurements.
INTRODUCTION
Work in our laboratory has shown that TRH has the capacity to reverse a variety of aging-related changes and alterations in old rodents [1, 2] . We also demonstrated rather unexpectedly that TRH acts directly in exerting its restorative effects and does not work through the thyroid gland by initiating increased synthesis or secretion of thyroid hormones [1, 2] . We suggest that TRH, a tripeptide with a high concentration in key tissues like the pineal gland, the pancreatic insulin-producing β cells, and the anterior hypothalamic area [3, 4] , serves as a vehicle for most fundamental energyregulating and hormone-synchronizing activities [5] .
The restoring effects of TRH could be observed in every animal model used, including aging and immunodeficient animals [1] , virus-infected and stressed mice [1] , hypothalamus-lesioned mice [2] , and particularly in old animals with typical age-related adiposity and progressive decay of neuroendocrine, immune, and hormonal functions [6] . TRH, when associated with melatonin, normalizes age-altered lipid metabolism and extends longevity in aging mice [7] . These findings led us to study the effects of short-term, acute administration and chronic, oral administration of TRH on *Address correspondence to this author at the Interbion Foundation for Basic Biomedical Research, Via San Gottardo 77, 6596 Gordola, Switzerland; E-mail: pierpaoli.fnd@bluewin.ch organs, tissues, and aging-related metabolic and hormonal markers. We were interested in exploring the effects under a range of dosage regimens and schedules of administration associated with a possible circadian cyclicity of its production and/or release [8, 9] . Additionally, we wanted to verify that it exerts anti-aging effects on two essential systems: gonadal-reproductive and kidney-urinary.
MATERIALS AND METHODS

Animals.
Inbred, male or female C57BL/6 and BALB/c mice raised in our animal rooms were used. They were given water and pellets ad libitum and kept in air-conditioned rooms at a temperature of 20 to 22°C. Lighting was regulated: lights were turned on at 7 A.M. and turned off at 7 P.M.
TRH. Synthetic and analytically pure tripeptide (TRHtartrate) was generously provided by Senn Chemicals (Dielsdorf, Switzerland). The TRH was dissolved in sterile twice-distilled water and immediately injected intraperitoneally (ip) for either short or long periods depending on the experimental protocol.
Blood assays. Between 8 and 10 A.M., blood samples were taken from the retro-orbital plexus under rapid ether anesthesia. Clotted blood was centrifuged, and serum samples were frozen until analysis. Peripheral blood counts were performed on fresh samples immediately after bleeding.
Oral treatment with TRH. TRH was given chronically in the drinking water at a dosage of 100 µg/mL. Water with or without TRH was changed every two days.
Light microscopy. Organs were taken after sacrifice, weighed, fixed in Bouin fluid, and embedded in paraffin. Three-to 5-µ slices were stained with hematoxylin-eosin.
RESULTS
The results demonstrate that administration of TRH to old mice, whether under short-term, acute conditions or under chronic, long-term oral conditions, results in a rapid correction of most aging-related hormonal and metabolic measurements to more juvenile levels (Tables 1-6 ). Mean ± SD, *P<0.05 when compared to old controls, (Student's t-test). 20-month-old C57BL/6 male mice were treated permanently (day and night) for 2 months with TRH tartrate in the drinking water at the concentration of 100 µg/mL. Mean ±SD,*p<0.05 when compared to old controls, **p<0.01 when compared to old controls (Student's t-Test). 20 month-old C57BL male mice were treated permanently (day and night) for 4 months with TRH-tartrate in the drinking water at the concentration of 100 µg/ml..
Acute Parenteral Treatment with TRH
Treatment with TRH for 10 days produces a rapid decline in triglycerides in aging and old BALB/c and C57BL/6 mice, with a less significant effect on cholesterol levels ( Table 1) . Acute evening treatment with 10 µg TRH for two weeks also modifies cholesterol and triglyceride levels significantly in aging, 15-month-old mice, moving them toward values closer to those typical in juveniles (Tables 2A and B) . When older, 18-month-old mice were used, morning administration of TRH for two weeks resulted in a modification to more juvenile blood levels of cholesterol, triglycerides, phospholipids, sodium, chloride, calcium, and creatine. Evening administration produced similar, but less dramatic, results (Tables 3A and B).
Chronic Oral Treatment with TRH (A) Effect on blood parameters.
Oral treatment for two months with TRH at a concentration of 100 µg/mL in the drinking water of 20-month-old C57BL/6 mice significantly increased peripheral blood levels of lymphocytes and reduced blood levels of cholesterol and triglycerides. Levels of thyroxin and plasma zinc were also altered positively ( Table 4) .
When treatment was continued for two more months, TRH positively corrected blood levels of lymphocytes, triglycerides, and thyroid hormones ( Table 5 ). The increase in these measurements was significant. Levels of cholesterol and testosterone were altered as well and became lower and higher, respectively, but the variation was not significant ( Table 5) .
(B) Effect on organs. The animals were bled and sacrificed at the end of the four-month period of TRH oral administration, and their organs were weighed immediately. Oral administration of TRH in the drinking water for four months resulted in a significant difference in organ weight, moving it toward juvenile values. The treatment produced an increase in thymus, testes, heart, and kidney weights and a reduction in adrenal weight ( Table 6 ).
(C) Effect on longevity. Daytime and nighttime treatment with TRH in the drinking water (100 µg/mL) of C57BL/6 mice beginning at 16 months of age did not produce a significant increase in longevity (Figs. 1 and 2) .
Effect of Chronic Oral Administration of TRH on Kidney and Testis Structure and Function: Light Microscopy Analysis
(A) Testes. Oral treatment with TRH for four months maintained testis function in aging mice to a remarkable degree (Fig. 3A-D) . TRH in the drinking water succeeded in maintaining and/or reconstituting testis structure and function, as demonstrated by the increase in weight of the testes and the active proliferation and formation of mature spermatogonia and a high rate of spermatogenesis in the follicles (B and D), when compared to untreated controls (A and C). TRH appears to greatly enhance the final stages of the maturation process of spermatogonia to spermatozoa.
(B) Kidneys. Treatment with TRH for four months protected the kidneys from amyloid and hyalin infiltration of tubuli and glomeruli, which typically occurs in aging mice (Fig.  4A-E) . In fact, large deposits of amyloid and hyalin material had infiltrated the shrunken glomeruli of untreated mice and filtration capacity was reduced (A and C), whereas such de-posits were barely present in TRH-treated mice (B and D). Massive hyalin degeneration was also observed in the blood vessel walls and in the tubules of untreated control mice (E).
DISCUSSION
Experiments involving subcutaneous and oral administration of TRH indicated remarkable aging-delaying and even what appeared to be aging-reversing effects of the neuropeptide TRH. Again, similarly to the actions of melatonin [10] , TRH acts as an anti-aging agent with a broad spectrum of activities that must necessarily be linked to a fundamental role in metabolic and hormonal regulation [10, 11] . It is impossible to believe that the variety of protective activities observed on stress, immunity, viruses, thyroid, lipids, and gonads depend on specific and limited tissue or cell-targeted effects. As suggested earlier [5] , we hypothesize that TRH, which is ubiquitous in nature [3] , influences basic mechanisms centrally located in the CNS like the anterior hypothalamic area and the pineal gland, as well as endocrine tissues like pancreatic β cells, regulating rapid adaptive responses like those of sugar levels in the blood [12] [13] [14] . Unlike the slow actions of melatonin, TRH administration has been shown in many models to rapidly and positively modify immunological and hormonal derangements [1, 2, 6, 7] .
The most remarkable and rapid TRH effects involve the adjustment of aging-altered lipids within just a few days. The lipid-lowering effects of TRH are more pronounced in older mice (compare Table 2 with Table 3 ). A significant improvement in kidney function, bone metabolism, glucose levels, sodium, and chloride were seen in 18-month-old TRH-treated mice, especially in those treated in the morning.
Under the experimental conditions in which TRH was administered chronically in the drinking water (100 µg/mL water) to 20-month-old C57BL/6 male mice, all typical aging-related alterations measured rapidly and significantly improved toward juvenile levels after two ( Table 4 ) and four ( Table 5 ) months of TRH oral supplementation. The positive changes took place in immunological values like peripheral blood lymphocyte number, metabolic derangements (lipid levels, thyroid hormones, and zinc). Zinc is a mineral whose decline follows aging precisely (Tables 4 and 5) .
The organs of the mice measured after four months of TRH administration were examined after humane sacrifice and these all showed a positive correction corresponding to the metabolic and hormonal changes in peripheral blood. The adrenal glands were not enlarged, which is something usually observed in aging-related hyper-corticosurrenalism, whereas thymus and testes maintained their weights appropriately for cellularity and function ( Table 6 ). Light microscopy analysis performed on testes and kidneys showed striking evidence for the maintenance of function and regression of aging. The experiment in which a four-month oral administration of TRH in C57BL/6 mice was administered starting at 20 months of age demonstrated clearly evident re- activation of spermatogenesis, as we had suspected would be the case on the basis of testes weight and testosterone levels (Figs. 3A-D) . Typical hyalin and amyloid degeneration of kidney glomerular and tubular structures was also prevented by TRH administration; these conditions affect all senescent mice (Figs. 4, A-E ).
These observations, although critical for the attribution of aging-delaying or -reversing properties to TRH as well as for Testicle of a 24-month-old C57BL/6 mouse, receiving TRH in the drinking water for 4 months at a dosage of 100µg/mL. Note total recovery of spermatogenesis. Hematoxylin-eosin, ×200. C). Testicle of a 24-month-old C57BL/6 mouse. Note atrophy and absence of active spermatogenesis. Hematoxylin-eosin, ×400. D). Testicle of a 24-month-old C57BL/6 mouse, after 4-month treatment with TRH in the drinking water (100 µg/mL). Note complete reconstitution of spermatogenesis and maintenance of function. Hematoxylin-eosin, ×400.
A) B)
C) D) E) Fig. (4). A) . Kidney of a 24-month-old C57BL/6 mouse. Note massive hyalin degeneration and glomerular atrophy. Hematoxylin-eosin, ×200. B). Kidney of a 24-month-old C57BL/6 mouse after 4-month treatment with TRH in the drinking water (100 µg/mL). Note the perfect maintenance and/or reconstitution of kidney structure and glomerular cellularity. Hematoxylin-eosin, ×200. C). Kidney of a 24-month-old C57BL/6 mouse. Note the massive glomerular sclerosis, atrophy, and hyalin degeneration. Hematoxylin-eosin, ×400. D). Kidney of a 24-month-old C57BL/6 mouse, after 4-month treatment with TRH in the drinking water (100 µg/mL). Note complete maintenance of glomerular structure and cellularity. Hematoxylin-eosin, ×400. E). Artery degeneration (sclerosis) in the kidney of a 24-month-old C57BL/6 mouse. Hematoxylin-eosin, °-400.
clinical applications of TRH for prevention and reversal of aging, do not allow us to speculate on its mechanism of action [12, 15, 16] . We can only suggest that TRH may be partly responsible, at least in mammals and via its stimulating effects on hypophyseal TSH, for the maintenance of thyroid function and for preventing its decay in senescence. Chronic (day and night) administration of TRH may not be the best conditions under which to evaluate the effects of this biologically active peptide. What remains to be done is for us to elaborate an approach to administration in human patients with different pathologic conditions that would mimic its actual circadian levels. The beneficial effects of TRH may be enhanced by cyclic administration following normal daynight variability [4, 9] . Independently from its proposed antiaging effects, TRH is in any case suitable for rapid correction of many of the most common metabolic and hormonal alterations associated with aging, taken alone or perhaps with melatonin [7] . Further studies will allow us to determine a supplementation dosage and schedule suitable for "resetting the hormonal clock" and that will delay or even reverse the aging process [17] .
